Recent developments in marginal zone lymphoma

Summary Marginal zone lymphoma is a relatively rare disease with a usually indolent clinical course. In clinical terms, three major subtypes—i.e., extranodal, nodal, and splenic marginal zone lymphomas—are encountered, which have specific clinical features. Clinical progress, however, has been limited in recent years as they are mostly lumped together with follicular lymphoma under the term “indolent lymphomas” in clinical trials. A talk given at the 2024 Annual Meeting of the Austrian Society of Hematology and Oncology aimed to summarize clinically relevant topics and progress in the field of marginal zone lymphoma, which is summarized in the current article.

Authors

Institutions

Publication Details

Journal
memo - Magazine of European Medical Oncology
Published
2024-11-04
DOI
https://doi.org/10.1007/s12254-024-00998-2
Citations
1
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recent developments in marginal zone lymphoma

Barbara Kiesewetter, Markus Raderer
1 citations
memo - Magazine of European Medical Oncology
Lymphoma Diagnosis and Treatment
0.42
article

Recent developments in marginal zone lymphoma

Barbara Kiesewetter, Markus Raderer
article en
1 citations

Abstract

Summary Marginal zone lymphoma is a relatively rare disease with a usually indolent clinical course. In clinical terms, three major subtypes—i.e., extranodal, nodal, and splenic marginal zone lymphomas—are encountered, which have specific clinical features. Clinical progress, however, has been limited in recent years as they are mostly lumped together with follicular lymphoma under the term “indolent lymphomas” in clinical trials. A talk given at the 2024 Annual Meeting of the Austrian Society of Hematology and Oncology aimed to summarize clinically relevant topics and progress in the field of marginal zone lymphoma, which is summarized in the current article.

memo - Magazine of European Medical OncologyVol. 17(4)
Medical University of Vienna (AT)
Medizinische Universität Wien
Openalex Percentile: Top 33%
Lymphoma Diagnosis and Treatment
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.